의지 및 보조기 : 시장 점유율 분석, 업계 동향과 통계, 성장 예측(2026-2031년)

According to Mordor Intelligence, the prosthetics and orthotics market size is expected to grow from USD 7.31 billion in 2025 to USD 7.68 billion in 2026 and is forecast to reach USD 9.88 billion by 2031 at 5.15% CAGR over 2026-2031.

This report is Segmented by Type [Orthotics (Lower-Limb Orthotics, and More), Prosthetics (Lower-Extremity Prosthetics and More), Technology (Conventional, Electric-Powered, and More), End User (Hospitals, P&O Clinics, Rehabilitation Centers, Home-Care, Military Facilities), and Geography (North America, Europe, and More). The Market Forecasts are Provided in Terms of Value (USD).

Global Prosthetics And Orthotics Market Trends and Insights

Rapid Rise in Diabetes-Related Amputations

Diabetes-linked lower-extremity amputations anchor baseline unit demand for prosthetic limbs, but they also catalyze reimbursement advocacy that ties advanced devices to limb-salvage outcomes. The International Diabetes Federation counted 588.7 million people with diabetes in 2024 and projects 852.5 million by 2050 . In the United States, roughly 165,000 amputation hospitalizations occur each year, with Black Americans experiencing a significantly higher incidence. Canada logged 7,720 diabetes-related amputations in its latest reporting cycle, underscoring pressures within single-payer systems. Manufacturers that embed residual-limb health sensors position themselves as partners in value-based care, moving revenue from episodic sales to recurring analytics subscriptions.

Ageing Population & Osteoarthritis Burden

The World Health Organization forecasts 2.1 billion people aged 60+ by 2050, up from 1.4 billion in 2024 . Knee osteoarthritis alone affects 365 million patients, fueling orthotic brace prescriptions that delay total-joint replacement. Japan, where 29% of residents are 65 years or older, incubates ultralight carbon-fiber ankle-foot orthoses now diffusing into Western markets. Vendors that pair braces with telerehabilitation platforms capture adherence data prized by payers seeking outcome-based payments.

Other drivers and restraints analyzed in the detailed report include:

1. Advances in Microprocessor & Myoelectric Technologies
2. Expanding Reimbursement in Developed Markets
3. High Device Cost & Uneven Reimbursement
4. Shortage of Certified O&P Clinicians

For complete list of drivers and restraints, kindly check the Table Of Contents.

Segment Analysis

Orthotics captured 58.1% of the Prosthetics and Orthotics market share in 2025, led by lower-limb bracing for 365 million knee-osteoarthritis patients. Spinal and upper-limb supports add stable revenue, benefiting from prefabricated SKUs ordered via e-commerce. Conversely, prosthetics contributed a smaller base yet will post a 6.22% CAGR, propelled by microprocessor-controlled knees that enable variable cadence. Consumables such as liners and suspension sleeves provide sticky recurring sales that anchor the Prosthetics and Orthotics market size growth across replacement cycles.

ISO 22523 and ISO 8549 compliance streamlines CE-marking and FDA 510(k) pathways. Orthotic commoditization risk rises as 3D-printing lowers entry barriers, whereas proprietary control algorithms protect prosthetic margins. Vendors bundling digital physiotherapy content with braces further differentiate in a crowded field.

Complete Report Scope:

• By Type
  • Orthotics
    • Lower-Limb Orthotics
      • Ankle-Foot Orthoses (AFO)
      • Knee Orthoses
      • Hip Orthoses
    • Upper-Limb Orthotics
    • Spinal Orthotics
  • Prosthetics
    • Lower-Extremity Prosthetics
      • Micro-processor Knees
      • Powered Ankles/Feet
    • Upper-Extremity Prosthetics
    • Liners, Sockets & Modular Components
• By Technology
  • Conventional / Body-Powered
  • Electric-Powered / Myoelectric
  • Micro-processor Controlled
  • Hybrid
  • 3D-Printed / Additive Manufactured
  • Robotic / Powered Exoskeletal
  • Sensory-Feedback Enabled
• By End User
  • Hospitals
  • Prosthetics & Orthotics Clinics
  • Rehabilitation Centers
  • Home-Care Settings
  • Other End Users
• By Geography
  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • Germany
    • United Kingdom
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • India
    • Japan
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • Middle East and Africa
    • GCC
    • South Africa
    • Rest of Middle East and Africa
  • South America
    • Brazil
    • Argentina
    • Rest of South America

Geography Analysis

North America held 43.3% of Prosthetics and Orthotics market share in 2025 on the strength of VA funding and Medicare reforms. Canada's single-payer model reimburses clinically necessary devices, yet long queues spur a parallel cash-pay segment. Mexico relies on charitable and medical-tourism flows, limiting premium uptake.

Europe ranks second by value; Germany's statutory system funds devices yet caps tariffs below full cost, driving volume but squeezing profitability. The European Union Medical Device Regulation stretches notified-body capacity, delaying product launches and dampening short-term Prosthetics and Orthotics market size addition.

Asia-Pacific is forecast for a 7.91% CAGR through 2031, fueled by India's Assistance to Disabled Persons subsidy, China's wider urban insurance coverage, and Japan's super-aged demographic looking for lightweight orthoses. South Korea and Australia exhibit high per-capita adoption within universal schemes. Southeast Asia remains cost-sensitive and favors low-cost mechanical limbs. The Middle East bifurcates between GCC states that reimburse premium devices and sub-Saharan Africa, where NGO donations dominate. South America's growth is tempered by fiscal constraints in Brazil and Argentina.

1. Bauerfeind
2. Blatchford Group
3. College Park Industries
4. Cyberdyne
5. Ekso Bionics
6. Enovis
7. Fillauer
8. Hanger Inc.
9. Integrum AB
10. Johnson & Johnson
11. Ortho Europe
12. Ossur
13. Ottobock
14. Proteor
15. Smiths Group
16. Spinal Technology Inc.
17. Steeper Group
18. Stryker
19. Thuasne
20. Trulife
21. WillowWood Global
22. Zimmer Biomet

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

TABLE OF CONTENTS

1 Introduction

• 1.1 Study Assumptions & Market Definition
• 1.2 Scope of the Study

2 Research Methodology

3 Executive Summary

4 Market Landscape

• 4.1 Market Overview
• 4.2 Market Drivers
  • 4.2.1 Rapid Rise in Diabetes-Related Amputations
  • 4.2.2 Ageing Population & Osteoarthritis Burden
  • 4.2.3 Advances In Micro-Processor & Myoelectric Technologies
  • 4.2.4 Expanding Reimbursement in Developed Markets
  • 4.2.5 AI-Driven Predictive Gait-Analytics Adoption
  • 4.2.6 Military R&D Spill-Over Into Civilian Devices
• 4.3 Market Restraints
  • 4.3.1 High Device Cost & Uneven Reimbursement
  • 4.3.2 Shortage of Certified O&P Clinicians
  • 4.3.3 Carbon-Fiber Supply-Chain Volatility
  • 4.3.4 Pay-For-Outcome Reimbursement Risk
• 4.4 Supply-Chain Analysis
• 4.5 Regulatory Landscape
• 4.6 Technological Outlook
• 4.7 Porter's Five Forces
  • 4.7.1 Threat of New Entrants
  • 4.7.2 Bargaining Power of Suppliers
  • 4.7.3 Bargaining Power of Buyers
  • 4.7.4 Threat of Substitutes
  • 4.7.5 Competitive Rivalry

5 Market Size & Growth Forecasts (Value, USD)

• 5.1 By Type
  • 5.1.1 Orthotics
    • 5.1.1.1 Lower-Limb Orthotics
      • 5.1.1.1.1 Ankle-Foot Orthoses (AFO)
      • 5.1.1.1.2 Knee Orthoses
      • 5.1.1.1.3 Hip Orthoses
    • 5.1.1.2 Upper-Limb Orthotics
    • 5.1.1.3 Spinal Orthotics
  • 5.1.2 Prosthetics
    • 5.1.2.1 Lower-Extremity Prosthetics
      • 5.1.2.1.1 Micro-processor Knees
      • 5.1.2.1.2 Powered Ankles/Feet
    • 5.1.2.2 Upper-Extremity Prosthetics
    • 5.1.2.3 Liners, Sockets & Modular Components
• 5.2 By Technology
  • 5.2.1 Conventional / Body-Powered
  • 5.2.2 Electric-Powered / Myoelectric
  • 5.2.3 Micro-processor Controlled
  • 5.2.4 Hybrid
  • 5.2.5 3D-Printed / Additive Manufactured
  • 5.2.6 Robotic / Powered Exoskeletal
  • 5.2.7 Sensory-Feedback Enabled
• 5.3 By End User
  • 5.3.1 Hospitals
  • 5.3.2 Prosthetics & Orthotics Clinics
  • 5.3.3 Rehabilitation Centers
  • 5.3.4 Home-Care Settings
  • 5.3.5 Other End Users
• 5.4 By Geography
  • 5.4.1 North America
    • 5.4.1.1 United States
    • 5.4.1.2 Canada
    • 5.4.1.3 Mexico
  • 5.4.2 Europe
    • 5.4.2.1 Germany
    • 5.4.2.2 United Kingdom
    • 5.4.2.3 France
    • 5.4.2.4 Italy
    • 5.4.2.5 Spain
    • 5.4.2.6 Rest of Europe
  • 5.4.3 Asia-Pacific
    • 5.4.3.1 China
    • 5.4.3.2 India
    • 5.4.3.3 Japan
    • 5.4.3.4 South Korea
    • 5.4.3.5 Australia
    • 5.4.3.6 Rest of Asia-Pacific
  • 5.4.4 Middle East and Africa
    • 5.4.4.1 GCC
    • 5.4.4.2 South Africa
    • 5.4.4.3 Rest of Middle East and Africa
  • 5.4.5 South America
    • 5.4.5.1 Brazil
    • 5.4.5.2 Argentina
    • 5.4.5.3 Rest of South America

6 Competitive Landscape

• 6.1 Market Concentration
• 6.2 Market Share Analysis
• 6.3 Company Profiles (includes Global level Overview, Market level overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share for key companies, Products & Services, and Recent Developments)
  • 6.3.1 Bauerfeind AG
  • 6.3.2 Blatchford Group
  • 6.3.3 College Park Industries
  • 6.3.4 Cyberdyne Inc.
  • 6.3.5 Ekso Bionics
  • 6.3.6 Enovis (DJO Global)
  • 6.3.7 Fillauer LLC
  • 6.3.8 Hanger Inc.
  • 6.3.9 Integrum AB
  • 6.3.10 Johnson & Johnson
  • 6.3.11 Ortho Europe
  • 6.3.12 Ossur
  • 6.3.13 Ottobock
  • 6.3.14 Proteor
  • 6.3.15 Smith & Nephew
  • 6.3.16 Spinal Technology Inc.
  • 6.3.17 Steeper Group
  • 6.3.18 Stryker Corporation
  • 6.3.19 Thuasne
  • 6.3.20 Trulife
  • 6.3.21 WillowWood Global
  • 6.3.22 Zimmer Biomet

7 Market Opportunities & Future Outlook

• 7.1 White-Space & Unmet-Need Assessment